Society Receives Positive CHRE Performance Review
Main Category: Pharmacy / PharmacistArticle Date: 06 Jul 2009 - 5:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
The Royal Pharmaceutical Society of Great Britain (RPSGB) has received a good performance review from the Council for Healthcare Regulatory Excellence (CHRE), the health professions' watchdog.
The independent report showed that the Society successfully met the required level of performance in all of its regulatory duties during the 2008 /2009 period, which it noted was a time of significant organisational change.
It also acknowledged the progress being made on the formation of the General Pharmaceutical Council (GPhC) and said; "We are impressed by the clear evidence we have seen of the RPSGB learning from the work of other regulators to enable it to improve its own performance."
Published today, the CHRE reports on the performance of all nine health professions regulators in the UK - looking at how each regulator functions and measuring their performance against agreed standards.
Wendy Harris, the Society's Deputy Registrar & Director of Regulation, said:
"The Society's regulatory teams must be congratulated on such a positive report. Although we have been and continue to work through a period of organisational upheaval, the Society has stayed committed to maintaining efficient and effective regulatory standards. "There is still a lot of preparatory and detailed work to be achieved before the GPhC opens its doors but we will continue to maintain our 'business as usual' approach until this transition occurs." In future, the GPhC will be subject to the annual CHRE performance review and not the RPSGB. The CHRE Performance Review for 2008 / 2009 is available in full from the CHRE website, http://www.chre.org.uk.
The Council for Healthcare Regulatory Excellence (CHRE)
CHRE is an independent statutory body covering all of the United Kingdom. It is accountable to the Westminster parliament. It was established by parliament in 2003 to ensure consistency and good practice in healthcare regulation.
The CHRE's primary purpose is to promote the health, safety and wellbeing of patients and the public. It scrutinises and oversees the health professions regulators, works with them to identify and promote good practice in regulation, carries out research, develops policy and gives advice.
The CHRE governs the following nine UK regulatory bodies:
- General Medical Council (GMC)
- Nursing and Midwifery Council (NMC)
- Health Professions Council (HPC)
- General Dental Council (GDC)
- General Optical Council (GOC)
- General Chiropractic Council (GCC)
- General Osteopathic Council (GOsC)
- Royal Pharmaceutical Society of Great Britain (RPSGB)
- Pharmaceutical Society of Northern Ireland (PSNI)
For further information visit the CHRE website, http://www.chre.org.uk.
Source
CHRE
Visit our pharmacy / pharmacist section for the latest news on this subject.
MLA
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/156482.php>
APA
http://www.medicalnewstoday.com/releases/156482.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



